Abstract
This chapter provides an illustrative practical overview of the utility of most CT and MRI techniques used for the clinical evaluation of the liver.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Dwyer A, et al. Influence of glycogen on liver density: computed tomography from a metabolic perspective. J Comput Assist Tomogr. 1983;7(1):70–3.
Kamel IR, Liapi E, Fishman EK. Multidetector CT of hepatocellular carcinoma. Best Pract Res Clin Gastroenterol. 2005;19(1):63–89.
Monzawa S, et al. Dynamic CT for detecting small hepatocellular carcinoma: usefulness of delayed phase imaging. AJR Am J Roentgenol. 2007;188(1):147–53.
Yeh BM, et al. Dual-energy and low-kVp CT in the abdomen. AJR Am J Roentgenol. 2009;193(1):47–54.
Mulkens TH. Dose management in Multidetector Computed Tomography (MDCT): modalities for dose reduction and clinical studies. Belgium: Universiteit Antwerpen; 2008. 223.
Boll DT, Merkle EM. Diffuse liver disease: strategies for hepatic CT and MR imaging. Radiographics. 2009;29(6):1591–614.
Goshima S, et al. MDCT of the liver and hypervascular hepatocellular carcinomas: optimizing scan delays for bolus-tracking techniques of hepatic arterial and portal venous phases. AJR Am J Roentgenol. 2006;187(1):W25–32.
Yu JS, et al. Hepatic MRI using the double-echo chemical shift phase-selective gradient-echo technique. AJR Am J Roentgenol. 2007;188(1):W49–56.
Deshmane A, et al. Parallel MR imaging. J Magn Reson Imaging. 2012;36(1):55–72.
Alustiza JM, Castiella A. Liver fat and iron at in-phase and opposed-phase MR imaging. Radiology. 2008;246(2):641.
Westbrook C, Roth CK, Talbot J. MRI in practice. 3rd ed. Malden: Blackwell; 2005. xii, 410 p.
Low RN. Abdominal MRI, advances in the detection of liver tumours and characterisation. Lancet Oncol. 2007;8(6):525–35.
Li T, Mirowitz SA. Fast T2-weighted MR imaging: impact of variation in pulse sequence parameters on image quality and artifacts. Magn Reson Imaging. 2003;21(7):745–53.
Huang J, et al. Utility of breath-hold fast-recovery fast spin-echo t2 versus respiratory-triggered fast spin-echo T2 in clinical hepatic imaging. AJR Am J Roentgenol. 2005;184(3):842–6.
Semelka RC. Abdominal-pelvic MRI. Hoboken: Wiley; 2006.
Leyendecker JR, Brown JJ, Merkle EM. Practical guide to abdominal & pelvic MRI. 2nd ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2011. ix, 406 p.
Morrin MM, Rofsky NM. Techniques for liver MR imaging. Magn Reson Imaging Clin N Am. 2001;9(4):675–96. v.
Taouli B, Koh DM. Diffusion-weighted MR imaging of the liver. Radiology. 2010;254(1):47–66.
Low RN, Gurney J. Diffusion-weighted MRI (DWI) in the oncology patient: value of breathhold DWI compared to unenhanced and gadolinium-enhanced MRI. J Magn Reson Imaging. 2007;25(4):848–58.
Chandarana H, Taouli B. Diffusion-weighted MRI and liver metastases. Magn Reson Imaging Clin N Am. 2010;18(3):451–64. x.
Bhosale P, Ma J, Choi H. Utility of the FIESTA pulse sequence in body oncologic imaging: review. AJR Am J Roentgenol. 2009;192(6 Suppl):S83–93. Quiz S94–7.
Motosugi U, et al. Delay before the hepatocyte phase of Gd-EOB-DTPA-enhanced MR imaging: is it possible to shorten the examination time? Eur Radiol. 2009;19(11):2623–9.
Tsao J, Kozerke S. MRI temporal acceleration techniques. J Magn Reson Imaging. 2012;36(3):543–60.
Yoon SH, et al. Multiphasic MDCT enhancement pattern of hepatocellular carcinoma smaller than 3 cm in diameter: tumor size and cellular differentiation. AJR Am J Roentgenol. 2009;193(6):W482–9.
Sadowski EA, et al. Nephrogenic systemic fibrosis: risk factors and incidence estimation. Radiology. 2007;243(1):148–57.
Reimer P, Schneider G, Schima W. Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications. Eur Radiol. 2004;14(4):559–78.
Karabulut N, Cakmak V, Kiter G. Confident diagnosis of bronchobiliary fistula using contrast-enhanced magnetic resonance cholangiography. Korean J Radiol. 2010;11(4):493–6.
Van Beers BE, Pastor CM, Hussain HK. Primovist, Eovist: what to expect? J Hepatol. 2012;57(2):421–9.
Husarik DB, et al. Contrast enhanced liver MRI in patients with primary sclerosing cholangitis: inverse appearance of focal confluent fibrosis on delayed phase MR images with hepatocyte specific versus extracellular gadolinium based contrast agents. Acad Radiol. 2011;18(12):1549–54.
Gschwend S, et al. Pharmacokinetics and imaging properties of Gd-EOB-DTPA in patients with hepatic and renal impairment. Invest Radiol. 2011;46(9):556–66.
Tamada T, et al. Dynamic contrast-enhanced magnetic resonance imaging of abdominal solid organ and major vessel: comparison of enhancement effect between Gd-EOB-DTPA and Gd-DTPA. J Magn Reson Imaging. 2009;29(3):636–40.
Tamada T, et al. Gd-EOB-DTPA-enhanced MR imaging: evaluation of hepatic enhancement effects in normal and cirrhotic livers. Eur J Radiol. 2011;80(3):e311–6.
Petersein J, et al. Focal liver lesions: evaluation of the efficacy of gadobenate dimeglumine in MR imaging–a multicenter phase III clinical study. Radiology. 2000;215(3):727–36.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Appendix A
Appendix A
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
Sagebiel, T., Szkarluk, J. (2015). Overview of CT and MRI Techniques of the Liver. In: Elsayes, K.M. (eds) Cross-Sectional Imaging of the Abdomen and Pelvis. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1884-3_1
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1884-3_1
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-1883-6
Online ISBN: 978-1-4939-1884-3
eBook Packages: MedicineMedicine (R0)